EPOR and cardiac hypertrophy: The inflammatory milieu has been reported to cause the downregulation of EPOR [36], hyporesponsiveness of ESA [37], and increase in fibroblast growth factor 23 [36], which induced myocardial hypertrophy [38,39] and diastolic dysfunction [40].